These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1) Title of each class of securities to which transaction applies:
|
|||||
|
2) Aggregate number of securities to which transaction applies:
|
||||||
|
3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
||||||
|
4) Proposed maximum aggregate value of transaction:
|
||||||
|
5) Total fee paid:
|
||||||
|
|
1) Amount Previously Paid:
|
||||
|
2) Form, Schedule or Registration Statement No.:
|
|||||
|
3) Filing Party:
|
|||||
|
4) Date Filed:
|
|||||
|
1.
|
To elect eleven (11) directors of the Company to serve until the 2020 Annual Meeting of Shareholders or until their successors are elected; and
|
|
2.
|
To ratify the selection of RSM US LLP as the Company’s independent registered public accountants for the fiscal year ending December 31, 2019; and
|
|
3.
|
To transact such other business as may properly come before the Annual Meeting, including adjourning the Annual Meeting to permit, if necessary, further solicitation of proxies or any adjournment thereof.
|
|
|
By Order of the Board of Directors
|
|
|
|
|
|
Blake S. Drexler
Chairman of the Board
|
|
New Canaan, Connecticut
|
|
|
April 18, 2019
|
|
|
•
|
Internet:
vote your shares at www.investorvote.com/BWFG
|
|
•
|
Telephone and Mail:
You can vote by telephone or mail by following the instructions on your proxy card.
|
|
•
|
At the Annual Meeting:
The method or timing of your vote will not limit your right to vote in person at the Annual Meeting. However, if your shares are held in the name of a broker, bank or other nominee, you must obtain a legal proxy, executed in your favor, from the holder of record to be able to vote at the Annual Meeting. You should allow yourself enough time prior to the Annual Meeting to obtain this proxy from the holder of record.
|
|
•
|
Internet:
vote your shares at www.investorvote.com/BWFG
|
|
•
|
Telephone and Mail:
You can vote by telephone or mail by following the instructions on your proxy card.
|
|
•
|
At the Annual Meeting:
The method or timing of your vote will not limit your right to vote in person at the Annual Meeting. However, if your shares are held in the name of a broker, bank or other nominee, you must obtain a legal proxy, executed in your favor, from the holder of record to be able to vote at the Annual Meeting. You should allow yourself enough time prior to the Annual Meeting to obtain this proxy from the holder of record.
|
|
|
Proposal
|
Required Vote
|
|
1.
|
Election of 11 directors
|
For each nominee, a plurality of the votes cast for such nominee.
|
|
2.
|
Ratification of the selection of the Company’s independent registered public accountants
|
A majority of the votes cast on the proposal.
|
|
Name
|
|
Age
|
|
Position with Bankwell Financial Group, Inc.
|
|
Position with
Bankwell Bank |
|
Director of
the Company Since |
|
George P. Bauer
|
|
87
|
|
Director
|
|
Director
|
|
2012
|
|
Gail E.D. Brathwaite
|
|
60
|
|
Director
|
|
Director
|
|
2017
|
|
Richard E. Castiglioni
|
|
67
|
|
Director
|
|
Director
|
|
2013
(2)
|
|
Eric J. Dale
|
|
54
|
|
Director
|
|
Director
|
|
2008
(3)
|
|
Blake S. Drexler
|
|
61
|
|
Director and Chairman
|
|
Director and Chairman
|
|
2007
(1)
|
|
James M. Garnett, Jr.
|
|
63
|
|
Director
|
|
Director
|
|
2018
|
|
Christopher R. Gruseke
|
|
58
|
|
Director, President and Chief Executive Officer
|
|
Director, President and Chief Executive Officer
|
|
2015
(4)
|
|
Daniel S. Jones
|
|
80
|
|
Director
|
|
Director
|
|
2007
(1)
|
|
Todd Lampert
|
|
55
|
|
Director and Corporate Secretary
|
|
Director and Corporate Secretary
|
|
2007
(1)
|
|
Victor S. Liss
|
|
82
|
|
Director
|
|
Director
|
|
2008
(3)
|
|
Carl M. Porto
|
|
76
|
|
Director
|
|
Director
|
|
2015
|
|
(1)
|
Director of the Bank of New Canaan from 2001-2013. As indicated above, present director of Bankwell Bank.
|
|
(2)
|
Director of the Bank of New Canaan from 2009-2013. As indicated above, present director of Bankwell Bank.
|
|
(3)
|
Director of the Bank of Fairfield from 2008-2013. As indicated above, present director of Bankwell Bank.
|
|
(4)
|
Director of the Bank of New Canaan from 2009-2011. Director of BNC Financial Group, Inc. from 2009-2012.
|
|
Name and Title
|
|
Amount and Nature of Beneficial Ownership
(1)
|
|
Percent of Class
|
|
|
|
|
|
|
|
5% Shareholders:
|
|
|
|
|
|
Lawrence B. Seidman
(2)
100 Lanidex Plaza, 1st Floor Parsippany, New Jersey 07054 |
|
654,026
|
|
8.31
|
|
Endicott Management Company
(3)
570 Lexington Avenue, 37th Floor New York, NY 10022 |
|
635,404
|
|
8.07
|
|
Banc Funds Co. LLC
(4)
20 North Wacker Drive Suite 3300 Chicago, IL 60606 |
|
477,232
|
|
6.06
|
|
Directors and Executive Officers:
|
|
|
|
|
|
George P. Bauer
(5)
|
|
405,366
|
|
5.15
|
|
Gail E.D. Brathwaite
|
|
17,200
|
|
*
|
|
Richard E. Castiglioni
|
|
14,800
|
|
*
|
|
Eric J. Dale
|
|
37,588
|
|
*
|
|
Blake S. Drexler
(6)
|
|
234,809
|
|
2.98
|
|
James M. Garnett, Jr.
|
|
1,200
|
|
*
|
|
Daniel S. Jones
(7)
|
|
254,662
|
|
3.23
|
|
Todd Lampert
(8)
|
|
35,892
|
|
*
|
|
Victor S. Liss
|
|
28,210
|
|
*
|
|
Carl M. Porto
(9)
|
|
17,835
|
|
*
|
|
Heidi DeWyngaert
(10)
|
|
66,125
|
|
*
|
|
Christopher Gruseke
(11)
|
|
130,618
|
|
1.66
|
|
Penko Ivanov
(12)
|
|
15,269
|
|
*
|
|
All directors and executive officers as a group
(15 persons) (13) |
|
1,283,100
|
|
16.30
|
|
(1)
|
Beneficially owned shares include shares over which the named person exercises either sole or shared voting power or sole or shared investment power. It also includes shares owned (i) by a spouse, minor children or by relatives sharing the same home, (ii) by entities owned or controlled by the named person and (iii) by other persons if the named person has the right to acquire such shares within 60 days of the exercise of any right or option. All shares identified above are owned of record individually or jointly or beneficially by the named person.
|
|
(2)
|
The amount shown is based solely on a Schedule 13D/A filed with the SEC on January 25, 2019.
|
|
(3)
|
The amount shown is based solely on a Schedule 13G/A filed with the SEC on February 14, 2018.
|
|
(4)
|
The amount shown is based solely on a Schedule 13G/A filed with the SEC on February 12, 2019.
|
|
(5)
|
Includes 153,895 shares that are held by the Bauer Foundation.
|
|
(6)
|
Includes 58,224 shares that are held in trusts over which he serves as trustee.
|
|
(7)
|
Includes 69,494 shares that are held jointly with spouse.
|
|
(8)
|
Includes 9,699 shares that are held jointly with spouse.
|
|
(9)
|
Includes 4,000 shares that are held in a pension plan.
|
|
(10)
|
Includes vested options to purchase 1,500 shares of common stock granted under the 2007 Plan. Includes 59,513 shares that are held jointly with her spouse.
|
|
(11)
|
Includes 71,795 shares that are held jointly with spouse.
|
|
(12)
|
Includes 590 shares that are held jointly with spouse.
|
|
(13)
|
Includes a total of two unnamed executive vice presidents holding 23,526 shares.
|
|
•
|
to assist our Board of Directors with its oversight of the integrity of our financial statements, financial reporting, and processes and systems of internal controls regarding finance, accounting, information technology and legal and regulatory compliance;
|
|
•
|
to establish qualifications for, select, and appoint our external auditors and internal auditors, pre-approve all audit and non-audit services to be provided, and establish the fees and other expenses to be paid to the external and internal auditors;
|
|
•
|
to oversee and monitor the independence and performance of our external auditors and internal auditing function;
|
|
•
|
to establish and oversee the Risk Management Program in accordance with policy;
|
|
•
|
to oversee the Audit Liaison function;
|
|
•
|
to establish procedures for the receipt, retention and treatment of complaints regarding accounting, internal controls or auditing matters, including confidential, anonymous submissions by employees of concerns regarding accounting, internal controls or auditing matters;
|
|
•
|
to monitor management action addressing existing or potential financial and operational control issues brought to the attention of the Committee by employees, internal or external auditors, other third-party review firms or regulators; and
|
|
•
|
to approve the Audit Committee Report required by the SEC to be included in the annual proxy statement.
|
|
•
|
to assist our Board of Directors in fulfilling its responsibilities with respect to the oversight of the Company’s affairs in the areas of employee compensation plans, policies and programs;
|
|
•
|
to determine specific executive officer (defined as all direct reports to the Chief Executive Officer, or as otherwise identified by our Board of Directors) compensation and benefits, and to approve and administer all executive officer contracts;
|
|
•
|
to develop and maintain incentive compensation programs that are designed to:
|
|
◦
|
reward high performance, promote accountability and adherence to our values and the code of conduct;
|
|
◦
|
align employee interests with the interests of our shareholders, through the use of equity plans;
|
|
◦
|
attract, develop and retain talented leadership to serve our long-term best interests;
|
|
◦
|
reflect appropriate consideration of current best practices for programs with similar goals and objectives; and
|
|
◦
|
avoid the encouragement of excessive risk-taking arising from our incentive compensation policies and practices, and mitigate material risks as necessary with effective controls and risk management processes; and
|
|
•
|
to monitor the performance of our management committee(s) administering any qualified and non-qualified benefit plans.
|
|
•
|
to oversee the composition of our Board of Directors and its committees, including developing a nominating process for our Board of Directors, developing criteria for board membership, recruitment of qualified candidates for our Board of Directors, reviewing and making recommendations to the Board of Directors concerning director succession planning, review of our Board of Directors size, committee structure and assignments of board members to serve on and to chair board committees;
|
|
•
|
to oversee our corporate governance policies and practices including, as appropriate, the development and recommendation to the Board of Directors for a set of corporate governance principles applicable to the Company, a board, committee and director assessment process, programs for orientation and continuing education programs for members of the Board of Directors and other related matters consistent with corporate governance best practices and compliance with NASDAQ corporate governance rules, if necessary; and
|
|
•
|
to develop a comprehensive list and schedule of board duties and responsibilities for review and approval by the Board in conjunction with the development of Corporate Governance Guidelines and, consistent with the Board's commitment to best practices and continuous improvement, to regularly review the scope and conduct of board meetings and the scope and content of information supplied to the Board and to make recommendations to the Board with respect to any enhancements therein.
|
|
Name and Principal Position
|
Year
|
Salary
($)
|
Bonus
($)
|
Stock
Awards
($)
(1)
|
Option
Awards
($)
|
Non-Equity
Incentive Plan
Compensation
($)
(2)
|
Nonqualified
Deferred
Compensation
Earnings
($)
|
All Other
Compensation
($)
(3)
|
Total
($)
|
|
Christopher R. Gruseke
President and CEO
(Company and Bank)
|
2018
|
550,000
|
-0-
|
330,200
|
-0-
|
192,500
|
-0-
|
10,156
|
1,082,856
|
|
2017
|
550,000
|
-0-
|
-0-
|
-0-
|
238,800
|
-0-
|
9,400
|
798,200
|
|
|
Penko Ivanov
EVP and CFO
(Company and Bank)
|
2018
|
300,000
|
-0-
|
165,100
|
-0-
|
75,000
|
-0-
|
8,751
|
548,851
|
|
2017
|
275,000
|
-0-
|
-0-
|
-0-
|
100,000
|
-0-
|
8,917
|
383,917
|
|
|
Heidi DeWyngaert
EVP and CLO
(Company and Bank)
|
2018
|
290,500
|
-0-
|
99,060
|
-0-
|
73,000
|
-0-
|
10,302
|
472,862
|
|
2017
|
284,322
|
-0-
|
-0-
|
-0-
|
87,200
|
-0-
|
14,976
|
386,498
|
|
|
(1)
|
These amounts represent the aggregate fair market value of shares granted (calculated in accordance with FASB ACS Topic 718) made to the executive officers named above, in all cases pursuant to the Company’s stock plans. All shares granted represent unvested restricted stock that will vest in accordance with the terms of the grant.
|
|
(2)
|
These amounts represent cash bonus incentives earned for performance in 2018 and 2017 as applicable, pursuant to the Executive Incentive Plan.
|
|
(3)
|
The 2018 amounts listed represent: For Mr. Gruseke, a $7,800 matching contribution made by the Company under the Company’s 401(k) Plan, a $993 life and AD&D insurance premium and $1,363 in BOLI imputed income; for Mr. Ivanov, a $7,800 matching contribution made by the Company under the Company’s 401(k) Plan, a $531 life and AD&D insurance premium and $420 in BOLI imputed income; and for Ms. DeWyngaert, a $7,800 matching contribution made by the Company under the Company's 401(k) Plan, a $1,584 life and AD&D insurance premium and $918 in BOLI imputed income.
|
|
|
|
|
|
Option awards
|
|
Stock awards
|
||||||||||
|
Name
|
|
Grant
Date
|
|
Number of
securities
underlying
unexercised
options
exercisable (#)
|
|
Option
exercise
price ($)
|
|
Option
expiration
date
|
|
Number of
shares or
units of
stock that
have
not vested
(#)
|
|
Market
value of
shares or
units of
stock that
have not
vested
($)
(4)
|
|
Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested (#)
|
|
Equity incentive plan awards: Market or payout value of unearned shares, units or other rights that have not vested
($)
(4)
|
|
Christopher R. Gruseke
(1)
|
|
2/20/2018
|
|
|
|
|
|
|
|
5,000
|
|
$143,550
|
|
5,000
|
|
$143,550
|
|
Penko Ivanov
(2)
|
|
9/26/2016
|
|
|
|
|
|
|
|
3,750
|
|
$107,663
|
|
|
|
|
|
|
|
2/20/2018
|
|
|
|
|
|
|
|
2,500
|
|
$71,775
|
|
2,500
|
|
$71,775
|
|
Heidi DeWyngaert
(3)
|
|
6/23/2009
|
|
1,500
|
|
$12.64
|
|
6/23/2019
|
|
|
|
|
|
|
|
|
|
|
|
12/9/2014
|
|
|
|
|
|
|
|
1,260
|
|
$36,175
|
|
|
|
|
|
|
|
12/9/2014
|
|
|
|
|
|
|
|
994
|
|
$28,538
|
|
|
|
|
|
|
|
2/20/2018
|
|
|
|
|
|
|
|
1,500
|
|
$43,065
|
|
1,500
|
|
$43,065
|
|
(1)
|
Mr. Gruseke was awarded 10,000 shares of restricted stock on February 20, 2018. The stock was valued at $33.02 per share. A total of 5,000 of those shares will vest in three substantially equal annual installments, with the first installment to vest on February 7, 2019 and the second and third installments to vest on each annual anniversary of the vesting date thereafter. A total of 5,000 of those shares are performance restricted stock and may vest when and if the performance goal is achieved.
|
|
(2)
|
Mr. Ivanov was awarded 7,500 shares of restricted stock on September 26, 2016. The stock was valued at $23.27 per share and vests over four (4) years as follows: 1,875 shares of common stock on September 26
th
in each of 2017, 2018, 2019 and 2020. Mr. Ivanov was awarded 5,000 shares of restricted stock on February 20, 2018. The stock was valued at $33.02 per share. A total of 2,500 of those shares will vest in three substantially equal annual installments, with the first installment to vest on February 7, 2019 and the second and third installments to vest on each annual anniversary of the vesting date thereafter. A total of 2,500 of those shares are performance restricted stock and may vest when and if the performance goal is achieved.
|
|
(3)
|
Ms. DeWyngaert was awarded 6,300 shares of restricted stock on December 9, 2014. The stock was valued at $18.99 per share and vests as follows: 1,260 shares on December 1 in each of 2015, 2016, 2017, 2018 and 2019. In December 2014 Ms. DeWyngaert was awarded market performance based restricted stock. In 2016, the Company restructured the performance based restricted stock and as a result 3,978 shares were modified to a time based grant and will vest in four substantially equal annual installments on December 1 in each of 2016, 2017, 2018 and 2019. Ms. DeWyngaert was awarded 3,000 shares of restricted stock on February 20, 2018. The stock was valued at $33.02 per share. A total of 1,500 of those shares will vest in three substantially equal annual installments, with the first installment to vest on February 7, 2019 and the second and third installments to vest on each annual anniversary of the vesting date thereafter. A total of 1,500 of those shares are performance restricted stock and may vest when and if the performance goal is achieved.
|
|
(4)
|
The closing price market value per share on December 31, 2018 was $28.71 per share.
|
|
•
|
$1,000 per board meeting;
|
|
•
|
$600 per Audit Committee and Directors Loan Committee meetings; and
|
|
•
|
$500 per Compensation, Governance and Nominating, Asset/Liability, Strategic, Community Reinvestment Act (CRA), and Technology Committee meetings.
|
|
•
|
$14,000 each for Audit Committee and Directors Loan Committee;
|
|
•
|
$10,000 each for Compensation, Governance and Nominating, and Technology Committee;
|
|
•
|
$8,000 for Asset/Liability Committee;
|
|
•
|
$7,500 for CRA Committee; and
|
|
•
|
$5,000 for Strategic Committee.
|
|
Name
|
|
Fees Earned
or Paid in
Cash ($)
|
|
Stock Awards ($)
(1)
|
|
Total
Compensation ($)
(2)
|
|
George P. Bauer
|
|
$36,500
|
|
$33,170
|
|
$69,670
|
|
Gail E.D. Brathwaite
|
|
54,267
|
|
33,170
|
|
87,437
|
|
Richard E. Castiglioni
|
|
56,975
|
|
33,170
|
|
90,145
|
|
Eric J. Dale
|
|
60,333
|
|
33,170
|
|
93,503
|
|
Blake S. Drexler
|
|
117,583
|
|
33,170
|
|
150,753
|
|
James A. Fieber
(3)
|
|
31,667
|
|
33,170
|
|
64,837
|
|
James M. Garnett, Jr.
(4)
|
|
26,000
|
|
—
|
|
26,000
|
|
Daniel S. Jones
|
|
57,933
|
|
33,170
|
|
91,103
|
|
Todd Lampert
|
|
66,033
|
|
48,355
|
|
114,388
|
|
Victor S. Liss
|
|
60,433
|
|
33,170
|
|
93,603
|
|
Carl M. Porto
|
|
38,000
|
|
33,170
|
|
71,170
|
|
Total
|
|
$605,724
|
|
$346,885
|
|
$952,609
|
|
(1)
|
Stock awards represent the fair market value on the date of the grant for any grants made during 2018 and excludes any stock vesting from grants made prior to 2018.
|
|
(2)
|
Compensation in the form of perquisites and other personal benefits provided by the Company has been omitted for each director as the total amount of those perquisites and personal benefits for each constituted less than $10,000 for the year ended December 31, 2018.
|
|
(3)
|
On July 14, 2018, Mr. Fieber, Vice Chairman of the Board and the Company, passed away. Mr. Fieber had been a member of the Company's Board since 2007.
|
|
(4)
|
Mr. Garnett joined the Board of Directors in April 2018.
|
|
•
|
we have been or are a participant;
|
|
•
|
the amount involved exceeds or will exceed $120,000; and
|
|
•
|
any of our directors, executive officers or beneficial holders of more than five percent of our capital stock, or any immediate family member of or person sharing the household with any of these individuals (other than tenants or employees), had or will have a direct or indirect material interest.
|
|
|
|
Fiscal Year Ended December 31,
|
||
|
|
|
2018
|
|
2017
|
|
Audit Fees
(1)
|
|
$396,196
|
|
$527,903
|
|
Tax Fees
(2)
|
|
61,201
|
|
92,234
|
|
All Other Fees
(3)
|
|
16,022
|
|
—
|
|
Total Fees
|
|
$473,419
|
|
$620,137
|
|
(1)
|
Includes fees for the financial statement audits and quarterly reviews.
|
|
(2)
|
Consists of tax return preparation and tax-related compliance services
|
|
(3)
|
Consists of benefit plan audit services.
|
|
|
By Order of the Board of Directors
|
|
|
|
|
|
Blake S. Drexler
Chairman of the Board
|
|
April 18, 2019
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|